NYX Technologies
Neurotechnology for Sleep Management and Stress Reduction
Company Overview
Snapshot
Founded in August 2016 by Ophir Orenstein, NYX Technologies operates with 11–50 employees. The company has secured seed funding across one disclosed round from three investors, with Corundum Neuroscience leading the round. A key milestone for the company was securing a patent for its neurotechnology.
Business overview
NYX Technologies develops neurotechnology for sleep management and stress reduction, primarily through its wearable device, Cognyx. This brain-tech headset stimulates and monitors brain activity, utilizing algorithms, software, and hardware to help users improve sleep cycles, analyze sleep patterns, and reduce stress. The device is complemented by a companion app for control and data analysis. Serving global markets, NYX Technologies operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Therapeutics, with applications in neurology, digital health, and wellness.
Strategic signal
In February 2023, NYX Technologies was featured in a Tech12 article highlighting its use of AI to address sleep problems, signaling the company's innovative approach to leveraging artificial intelligence in its neurotechnology. This indicates a strategic focus on advanced technological integration to enhance product efficacy and market positioning within the competitive digital health landscape.
Log in to access full profile ›Company Intelligence Q&A
- What is NYX Technologies' core product?
- NYX Technologies' core product is Cognyx, a wearable brain-tech headset designed to stimulate and monitor brain activity to improve sleep and reduce stress. It combines specialized algorithms, software, and hardware for an accessible user experience.
- When was NYX Technologies founded?
- NYX Technologies was founded in August 2016.
- Who is a co-founder of NYX Technologies?
- Ophir Orenstein is a co-founder and CTO of NYX Technologies.
- Has NYX Technologies secured any patents?
- Yes, NYX Technologies holds a patent related to its neurotechnology.
- Which investor led NYX Technologies' seed funding round?
- Corundum Neuroscience led NYX Technologies' seed funding round in February 2020.